PHS
AGN

PFM Health Sciences’s Allergan plc AGN Stock Holding History

PFM Health Sciences’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-281,548
Closed -$53.8M – 84
2019
Q4 		$53.8M Sell
281,548
-174,050
-38% -$31.4M 2.56% 13
2019
Q3 		$76.7M Sell
455,598
-1,329,999
-74% -$217M 2.26% 12
2019
Q2 		$299M Buy
1,785,597
+1,210,760
+211% +$168M 5.68% 2
2019
Q1 		$84.2M Buy
+574,837
New +$83.3M 1.86% 17
2018
Q4 		– Sell
-689,949
Closed -$131M – 132
2018
Q3 		$131M Buy
+689,949
New +$127M 1.93% 9
2017
Q4 		– Sell
-428
Closed -$88K – 108
2017
Q3 		$88K Buy
+428
New +$99.5K ﹤0.01% 87
2016
Q2 		– Sell
-314,106
Closed -$84.2M – 109
2016
Q1 		$84.2M Sell
314,106
-178,353
-36% -$51.1M 2.6% 12
2015
Q4 		$154M Sell
492,459
-116,330
-19% -$34.6M 4.68% 3
2015
Q3 		$165M Buy
+608,789
New +$187M 4.65% 6
2015
Q2 		– Sell
-127,756
Closed -$38M – 116
2015
Q1 		$38M Sell
127,756
-290,271
-69% -$82.8M 1.05% 38
2014
Q4 		$108M Sell
418,027
-271,924
-39% -$68M 2.51% 9
2014
Q3 		$166M Sell
689,951
-89,525
-11% -$20M 3.83% 6
2014
Q2 		$174M Sell
779,476
-252,666
-24% -$52.3M 3.48% 10
2014
Q1 		$212M Sell
1,032,142
-153,893
-13% -$30.5M 3.85% 6
2013
Q4 		$199M Buy
1,186,035
+1,119,376
+1,679% +$175M 4.01% 7
2013
Q3 		$9.6M Sell
66,659
-692,554
-91% -$92.3M 0.23% 56
2013
Q2 		$95.8M Buy
+759,213
New +$86M 1.99% 18

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PFM Health Sciences's AGN Position: Q1 2020 in Review

PFM Health Sciences sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 281,548 shares — an estimated $53.8M sold.

PFM Health Sciences first reported a position in AGN in Q2 2013 and held it in 17 quarters. The position peaked at $299M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • PFM Health Sciences reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • PFM Health Sciences sold 281,548 Allergan plc shares in Q1 2020, an estimated $53.8M.
  • PFM Health Sciences first reported a position in Allergan plc in Q2 2013 and held it in 17 quarters.
  • PFM Health Sciences's Allergan plc position peaked at $299M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.